Anping Zheng

Systemic Inflammation Biomarkers Predict Survival in Patients of Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy - A Single Center Experience

Hui Luo, Hong Ge, Yingying Cui et al. · Journal of Cancer · 2017 · 56 citations · Full text

NR2F1-induced NR2F1-AS1 promotes esophageal squamous cell carcinoma progression via activating Hedgehog signaling pathway

Yaowen Zhang, Anping Zheng, Ruiping Xu et al. · Biochemical and Biophysical Research Communications · 2019 · 34 citations

Cancer Research, Esophageal Cancer, Oncogenic Agent +8

Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancer

Shixiu Wu, Lvhua Wang, Honglei Luo et al. · European Journal of Cancer · 2018 · 27 citations

Concurrent Chemoradiotherapy, Radiation Medicine, Esophageal Cancer +10

Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial

Congying Xie, Jing Zhao, Honglei Luo et al. · British Journal of Cancer · 2020 · 27 citations · Full text

Thoracic Radiotherapy Improves the Survival in Patients With <i>EGFR</i> -Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial

Hongfu Sun, Minghao Li, Wei Huang et al. · Journal of Clinical Oncology · 2024 · 26 citations